|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.89 USD | -0.10% |
|
+5.84% | -28.11% |
| Dec. 12 | Morgan Stanley Adjusts Moderna Price Target to $28 From $30, Maintains Equalweight Rating | MT |
| Dec. 12 | Rate Cuts Can't Buy Confidence |
Official Publications
| Nov. 05 | Slide show Q3 | CO |
| Nov. 05 | 3rd quarter results | CO |
| Nov. 05 | SEC Filing 10Q-3 | CO |
| Nov. 05 | SEC Filing 8K | CO |
| Jul. 31 | Slide show half-year results | CO |
| Jul. 31 | 1st-half-year results | CO |
| Jul. 31 | SEC Filing 8K | CO |
| Jul. 31 | SEC Filing 10Q-2 | CO |
| Apr. 30 | Slide show Q1 | CO |
| Apr. 30 | 1st quarter results | CO |
| Apr. 30 | SEC Filing 10Q-1 | CO |
| Apr. 30 | SEC Filing 8K | CO |
| Apr. 29 | Shareholders meeting voting results | CO |
| Mar. 10 | Proxy Statments | CO |
| Feb. 20 | SEC Filing 10K | CO |
| Feb. 13 | Slide show results | CO |
| Feb. 13 | Annual results | CO |
| Feb. 13 | SEC Filing 8K | CO |
| Feb. 11 | SEC Filing 13G | CO |
| Nov. 06 | Slide show Q3 | CO |
| Nov. 06 | 3rd quarter results | CO |
| Nov. 06 | SEC Filing 8K | CO |
| 24-10-01 | Changes in management and corporate officers | CO |
| 24-07-31 | Slide show half-year results | CO |
| 24-07-31 | 1st-half-year results | CO |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Official Publications
Select your edition
All financial news and data tailored to specific country editions

















